Ahsan Farooqi, M.D., Ph.D.
Department of Radiation Oncology, Division of Radiation Oncology
About Dr. Ahsan Farooqi
Dr. Ahsan Farooqi is an Assistant Professor in the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. Before his appointment as faculty, he received his MD and PhD at the Texas Tech University Health Sciences Center School of Medicine (Lubbock, TX), followed by residency training at the University of Texas Dell Medical School (Austin, TX) and MD Anderson Cancer Center.
In his appointment to the Melanoma & Sarcoma Radiation Oncology section he specializes in the treatment of bone and soft tissue sarcomas, melanomas, and other non-melanoma skin malignancies. He has clinical expertise in a variety of standard and specialized radiation treatment modalities including intensity modulated radiation therapy (IMRT/VMAT), proton therapy, stereotactic body radiation therapy (SBRT), and 3D conformal radiation (photons/electrons).
His research is focused on identifying novel ways to combine radiation therapy with targeted agents such as DNA-damage response inhibitors and immunotherapy, to improve outcomes of patients. He has received funding from extramural sources including the Radiological Society of North America (RSNA) and his research has been presented at international conferences and published across a variety of peer-reviewed medical journals.
Read More
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Radiation Oncology Department, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas, US, MD |
| 2013 | Texas Tech University Health Sciences Center Graduate School of Biomedical Sciences, Lubbock, Texas, US, Ph.D. in Cell and Molecular Biology |
| 2008 | Texas A&M University, College Station, Texas, US, BS in Biomedical Sciences |
Postgraduate Training
| 2016-2020 | Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2015-2016 | Clinical Internship, Internal Medicine, The University of Texas Dell Medical School, Austin, Texas |
Board Certifications
| 2021 | American Board of Radiology |
Experience & Service
Administrative Appointments/Responsibilities
Director Radiation Biology Course, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Institutional Committee Activities
Member, Data and Biospecimen Access Committee (DBAC), 2024 - Present
Member, Department of Radiation Oncology Spatially Fractionated Radiation Therapy (SFRT) Working Group, 2023 - Present
Member, PRS Faculty Compensation & Benefit Advisory Committee, 2023 - Present
Member, Plastic Surgery Chair Search Committee, 2023 - Present
Member, Department of Radiation Oncology ROSI X-Met Pillar Working Group, 2023 - Present
Member, Breast Sarcoma Clinical Care Algorithm Working Group, 2022 - Present
Member, Sarcoma Multidisciplinary Planning Conference, 2022 - Present
Member, Department of Radiation Advance Care Planning Working Group, 2022 - Present
Member, Division of Radiation Oncology Safety Committee, 2021 - Present
Member, Department of Radiation Oncology Weekend Simulation Working Group, 2021 - 2022
Melanoma/Sarcoma Radiation Oncology Network Lead, MD Anderson Cancer Network, 2021 - Present
Member, Faculty Senate, 2021 - 2024
Member, Department of Radiation Oncology Residency Interview Committee, 2020 - Present
Honors & Awards
| Valedictorian, Killeen High School | |
| President's Scholarship, Texas A&M University | |
| Science Program for Excellence in Science Scholarship, American Association for the Advancement of Science | |
| Achievement Rewards for College Scientists Fellow and Scholar, Achievement Rewards for College Scientists Foundation | |
| Alpha Omega Alpha Honor Medical Society, Texas Tech University Health Sciences Center School of Medicine | |
| Leonard B. Holman Research Pathway Scholar, American Board of Radiology | |
| Resident Research Grant, Radiological Society of North America | |
| ROSI Education Grant, MD Anderson Cancer Center- Department of Radiation Oncology | |
| 2023-2024 Association of Residents in Radiation Oncology (ARRO) Educator of the Year, The University of Texas- MD Anderson Cancer Center |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Dharmaiah S, Malgulwar PB, Johnson WE, Chen BA, Sharin V, Whitfield BT, Alvarez C, Tadimeti V, Farooqi AS, Huse JT. G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target ATRX-deficient malignant glioma. Neuro Oncol None(None):None, 2024. PMID: 39570009.
- Keatts SA, Salem AF, Swanson DM, Farooqi AS, Bishop AJ, Amaria RN, McQuade JL, Glitza Oliva IC, Diab A, Weiser R, Fisher SB, Goepfert RP, Ross MI, Ashleigh Guadagnolo B, Mitra D. Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma. Clin Transl Radiat Oncol 49(None):100856, 2024. PMID: 39308633.
- Yoder AK, Farooqi A, Mitra D, Livingston JA, Araujo DM, Sturgis EM, Goepfert R, Bishop AJ, Guadagnolo BA. Outcomes for Patients With Head and Neck Sarcoma Treated Curatively With Radiation Therapy and Surgery. Pract Radiat Oncol 14(5):e373-e382, 2024. PMID: 38851534.
- Bishop AJ, Mitra D, Farooqi A, Swanson DM, Hempel C, Willis T, Pearlnath C, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Guadagnolo BA. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes. Cancer None(None):None, 2024. PMID: 39192597.
- Deboever N, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Heymach JV, Gomez DR, Gandhi SJ, Antonoff MB. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease. J Thorac Cardiovasc Surg 167(6):1929-1935.e2, 2024. e-Pub 2023. PMID: 37619884.
- Nasr, L, Zoghbi, M, Segura Lazcano, R, Nakazawa, MS, Bishop, AJ, Farooqi, AS, Mitra, D, Guadagnolo, BA, Benjamin, RS, Patel, S, Ravi, V, Araujo, DM, Livingston, JA, Zarzour, MA, Conley, AP, Ratan, R, Somaiah, N, Lazar, A, Roland, CL, Keung, EZ, Nassif, EF. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade. Cancers 16(9), 2024. PMID: 38730715.
- Cass S, Cope B, Bishop AJ, Chiang YJ, Guadagnolo BA, Farooqi A, Morrison W, Witt RG, Seervai RNH, Garden AS, Fuller CD, Goepfert RP, Ross M, Gershenwald JE, Wong M, Aung PP, Keung EZ, Mitra D. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. Radiother Oncol 188:109892, 2023. e-Pub 2023. PMID: 37659660.
- Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Guadagnolo BA, Nguyen QN, Bishop AJ. Stereotactic Ablative Radiation Therapy for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection. Int J Radiat Oncol Biol Phys 114(3):s82, 2023. e-Pub 2023. PMID: 37914142.
- Yoder AK, Farooqi AS, Wernz C, Subramaniam A, Ravi V, Goepfert R, Sturgis EM, Mitra D, Bishop AJ, Guadagnolo BA. Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy. Head Neck 45(8):1943-1951, 2023. e-Pub 2023. PMID: 37272774.
- De B, Farooqi AS, Mitchell KG, Ludmir EB, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee JJ, Swisher SG, Gibbons DL, Zhang J, Le X, Elamin YY, Gomez DR, Ning MS, Lin SH, Liao Z, Chang JY, Vaporciyan AA, Heymach JV, Antonoff MB, Gandhi SJ. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO Precis Oncol 7:e2200540, 2023. PMID: 36716413.
- Florez MA, De B, Cavazos A, Farooqi A, Beckham TH, Wang C, Yeboa DN, Bishop AJ, McAleer MF, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol 13(1):e7-e13, 2023. e-Pub 2022. PMID: 36604100.
- Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, Preoperative Radiotherapy for Patients with Soft Tissue Sarcomas (HYPORT-STS): a Single-centre, Open-label, Single-arm, Phase 2 Trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
- Mitra D, Farr M, Nagarajan P, Ho J, Bishop AJ, Jhingran A, Farooqi AS, Frumovitz M, Amaria RN, McQuade JL, Jazaeri AA, Guadagnolo BA. Gynecologic Tract Melanoma in the Contemporary Therapeutic Era: High Rates of Local and Distant Disease Progression. Gynecol Oncol 167(3):483-489, 2022. e-Pub 2022. PMID: 36229264.
- Bishop AJ, Amini B, Lin H, Raza SM, Patel S, Grosshans DR, Ghia A, Farooqi A, Guadagnolo BA, Mitra D, Akdemir KC, Lazar AJ, Wang WL, Alvarez-Breckenridge C, Bird J, Rhines LD, Somaiah N, Conley AP. Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. J Immunother 45(8):374-378, 2022. e-Pub 2022. PMID: 35943386.
- Bishop AJ, Zheng J, Subramaniam A, Ghia AJ, Wang C, McGovern SL, Patel S, Guadagnolo BA, Mitra D, Farooqi A, Reardon MJ, Kim B, Guha-Thakurta N, Li J, Ravi V. Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention. Am J Clin Oncol 45(6):258-263, 2022. e-Pub 2022. PMID: 35588225.
- Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Walsh GL, Gandhi S, Gomez DR, Vaporciyan AA. Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC. JTO Clin Res Rep 3(3):100288, 2022. e-Pub 2022. PMID: 35252897.
- Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant Checkpoint Inhibitor Immunotherapy for Resectable Mucosal Melanoma. Front Oncol 12:1001150, 2022. e-Pub 2022. PMID: 36324592.
- Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo DM, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions. Adv Radiat Oncol 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
- Mitra D, Rao PK, Nagarajan P, Bishop AJ, Farooqi AS, Gershenwald JE, Wargo J, Keung EZ, Fisher SB, Amaria RN, Davies MA, Ross MI, Guadagnolo BA. Outcomes after Sphincter-sparing Local Therapy for Anorectal Melanoma: 1989-2020. Pract Radiat Oncol 12(5):437-445, 2022. e-Pub 2022. PMID: 35278716.
- Farooqi A, Ludmir EB, Mitchell KG, Antonoff MB, Tang C, Lee P, Chang J, Elamin Y, Gomez DR, Gandhi SJ. Increased Biologically Effective Dose (BED) to the Primary Tumor is Associated with Improved Survival in Patients with Oligometastatic NSCLC. Radiother Oncol 163:114-118, 2021. e-Pub 2021. PMID: 34419505.
- Koneru B, Farooqi A, Nguyen TH, Chen WH, Hindle A, Eslinger C, Makena MR, Burrow TA, Wilson J, Smith A, Pilla Reddy V, Cadogan E, Durant ST, Reynolds CP. ALT Neuroblastoma Chemoresistance Due to Telomere Dysfunction-induced ATM Activation is Reversible with ATM Inhibitor AZD0156. Sci Transl Med 13(607), 2021. PMID: 34408079.
- Mitra D, Ologun G, Keung EZ, Goepfert RP, Amaria RN, Ross MI, Gershenwald JE, Lucci A, Fisher SB, Davies MA, Lee JE, Bishop AJ, Farooqi AS, Wargo J, Guadagnolo BA. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era. Ann Surg Oncol 28(7):3480-3489, 2021. e-Pub 2021. PMID: 33856603.
- Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Sepesi B, Gomez DR, Antonoff MB, MD Anderson Cancer Center Oligometastatic Lung Cancer Working Group MD. Pulmonary Resection is Associated with Long-term Survival and Should Remain a Therapeutic Option in Oligometastatic Lung Cancer. J Thorac Cardiovasc Surg 161(4):1497-1504.e2, 2021. e-Pub 2020. PMID: 32331820.
- Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist 26(3):250-260, 2021. e-Pub 2020. PMID: 33289298.
- Koneru B, Lopez G, Farooqi A, Conkrite KL, Nguyen TH, Macha SJ, Modi A, Rokita JL, Urias E, Hindle A, Davidson H, Mccoy K, Nance J, Yazdani V, Irwin MS, Yang S, Wheeler DA, Maris JM, Diskin SJ, Reynolds CP. Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma. Cancer Res 80(12):2663-2675, 2020. e-Pub 2020. PMID: 32291317.
- Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB. Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer. Clin Lung Cancer 21(1):37-46.e7, 2020. e-Pub 2019. PMID: 31447303.
- Farooqi A, Yang J, Sharin V, Ezhilarasan R, Danussi C, Alvarez C, Dharmaiah S, Irvin D, Huse J, Sulman EP. Identification of Patient-derived Glioblastoma Stem Cell (GSC) Lines with the Alternative Lengthening of Telomeres Phenotype. Acta Neuropathol Commun 7(1):76, 2019. e-Pub 2019. PMID: 31097032.
- Farooqi A, Bishop AJ, Narang S, Allen PK, Li J, McAleer MF, Tatsui CE, Rhines LD, Amini B, Wang XA, Ghia AJ. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery. Pract Radiat Oncol 9(2):e142-e148, 2019. e-Pub 2018. PMID: 30385151.
- Farooqi A, Holliday EB, Allen PK, Wei X, Cox JD, Komaki R. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?. Radiother Oncol 122(2):307-312, 2017. e-Pub 2017. PMID: 28073578.
- Farooqi A, Dagg RA, Choi LM, Shay JW, Reynolds CP, Lau LM. Alternative Lengthening of Telomeres in Neuroblastoma Cell Lines is Associated with a Lack of MYCN Genomic Amplification and with p53 Pathway Aberrations. J Neurooncol 119(1):17-26, 2014. e-Pub 2014. PMID: 24792489.
- Farooqi A, Siddiqi A, Khan MK, Esiashvili N. Evaluation of Radiation Dose to Cardiac and Pulmonary Tissue Among Patients with Stage IV Wilms Tumor and Pulmonary Metastases. Pediatr Blood Cancer 61(8):1394-7, 2014. e-Pub 2014. PMID: 24585510.
Invited Articles
- Farooqi AS, Guadagnolo BA, Mitra D, Bishop AJ. Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation. Curr Oncol 30(1):598-609, 2023. e-Pub 2023. PMID: 36661696.
Manuals, Teaching Aids, Other Teaching Publications
- Farooqi A. IAEA Radiobiology Modules. None, 2024.
- . Sarcoma and Skin Disease Site Editor – Radonc Questions Online Question Bank- https://www.radoncquestions.com/. None, 2020.
Other Articles
- Farooqi A, Mitra D, Guadagnolo BA, Bishop AJ The Evolving Role of Radiation Therapy in Patients with Metastatic Soft Tissue Sarcoma. Curr Oncol Rep 22(8):79, 2020. PMID: 32602007.
- Farooqi A, Li J, de Groot J, Yeboa DN Current Role of Radiation Therapy in the Management of Malignant Central Nervous System Tumors. Hematol Oncol Clin North Am 34(1):13-28, 2020. PMID: 31739940.
- Farooqi A, Sun TL, Thang S, Shaitelman SF Treatment of Bilateral Breast Cancer and Regional Nodes Using an Opposed Lateral Beam Arrangement. Pract Radiat Oncol 7(6):e385-e389, 2017. PMID: 28867548.
Abstracts
- Keatts S, Swanson D, Farooqi A, Bishop AJ, Amaria R, McQuade J, Glitza I, Diab A, Weiser R, Fisher S, Ross MI, Guadagnolo BA, Mitra D. Hypofractionated Radiation Therapy for Unresectable or Bulky Metastatic Melanoma. Int J Radiat Oncol Biol Phys 123(2):S180-S181, 2024. PMID: None.
- Arifin AJ, Jerez O, Keatts S, Salem AFM, Farooqi A, Bishop AJ, Yoder AK, Goepfert RP, Weiser R, Amaria R, McQuade J, Ross MI, Guadagnolo BA, Mitra D. Adjuvant Primary Site Radiation Therapy for Melanoma in the Immunotherapy Era. Int J Radiat Oncol Biol Phys 120(2):S179-S180, 2024. PMID: None.
- Salem AFM, Chen M, McQuade J, Amaria R, Swanson D, Williams MD, Farooqi A, Bishop AJ, Hanna EY, Guadagnolo BA, Su SY, Mitra D. Sinonasal Melanoma Outcomes after Neoadjuvant Immunotherapy. Int J Radiat Oncol Biol Phys 120(2):e483-e484, 2024. PMID: None.
- Dudzinski SO, Farooqi A, Roy S, Bishop AJ, Swanson D, Nagarajan P, Amaria R, McQuade J, Weiser R, Fisher S, Ross MI, Guadagnolo BA, Mitra D. Evaluation of Genomic and Pathologic Features Associated with Outcomes among Patients with Sentinel Lymph Node-Positive Melanoma in the Contemporary Era. Int J Radiat Oncol Biol Phys 120(2):S180, 2024. PMID: None.
- Arifin AJ, Bishop AJ, Mitra D, Araujo D, Haddad Nassif EF, Ratan R, Livingston JA, Lewis V, Lin P, Moon B, Keung E, Roland CL, Scally C, Guadagnolo BA, Farooqi A. Outcomes Following Combined Modality Treatment to the Primary Site in Patients with Metastatic Soft Tissue Sarcoma. Int J Radiat Oncol Biol Phys 120(2):e426-e427, 2024. PMID: None.
- Mitra D, Gonzalez C, Swanson D, Bishop AJ, Farooqi A, Garden AS, Morrison WH, Goepfert RP, Esmaeli B, Ross MI, Wong MK, Ivan D, Guadagnolo BA. Adjuvant Radiation Therapy Improves Local Control in the Treatment of Adnexal Carcinoma. Int J Radiat Oncol Biol Phys 117(2):e325-326, 2023. PMID: None.
- Yoder AK, Netherton T, Wang XA, Lim TY, Wang H, Luo D, Wang C, Thrower SL, Farooqi A, Mitra D, Bishop AJ, Guadagnolo BA. Evaluating the Utility of Traditional Bowel Dose Constraints When Treating Abdominal and Pelvic Sarcomas with Preoperative Radiation Therapy. Int J Radiat Oncol Biol Phys 117(2):e353-e354, 2023. PMID: None.
- Yoder AK, Farooqi A, Mitra D, Livingston JA, Arujo D, Sturgis EM, Goepfert RP, Bishop AJ, Guadagnolo BA. Outcomes for Patients with Head and Neck Sarcoma Treated Curatively with Radiation Therapy and Surgery. Int J Radiat Oncol Biol Phys 117(2):s149-s150, 2023. PMID: None.
- Cope B, Bishop AJ, Guadagnolo BA, Morrison WH, Witt RG, Chiang YJ, Farooqi A, Seervai RNH, Garden AS, Fuller CD, Goepfert RP, Gershenwald JE, Ross MI, Wong MK, Aung PP, Keung E, Mitra D. Anatomic Variability in Patterns of Care for Locoregional Merkel Cell Carcinoma (MCC) Management at a Large Referral Center. Int J Radiat Oncol Biol Phys 114(3):e603-e603, 2022. PMID: None.
- Farooqi A, Yoder AK, Pasalic D, Erasmus J, Wernz C, Mitra D, Somaiah N, Conley AP, Ratan R, Livingston JA, Roland CL, Scally C, Keung E, Gandhi S, Guadagnolo BA, Nguyen QN, Bishop AJ. Stereotactic Ablative Radiation Therapy for Sarcoma Lung Metastases: Indications for Treatment and Patterns of Failure. Int J Radiat Oncol Biol Phys 114(3):S82, 2022. PMID: None.
- Dharmaiah S, Chen, Malgulwar PB, Tadimeti V, Farooqi A, Huse J. Characterizing the Genomic Consequences of G-Quadruplex Stabilization in ATRX-deficient High-grade Glioma. Neuro- Oncology 24(Supplement_7):vii92-vii93, 2022. PMID: None.
- Mohiuddin IS, Bishop AJ, Mitra D, Guadagnolo BA, McCutcheon IE, Raza SM, Yeboa DN, McAleer MF, Li J, Ghia AJ, Farooqi A. Gross Tumor Resection Followed by Post-Operative Radiation Optimizes Local Control in Patients with Meningeal Hemangiopericytoma: An Update on a Single Institutional Experience. Int J Radiat Oncol Biol Phys 114(3):e83-e84, 2022. PMID: None.
- Mitra D, Farr M, Nagarajan P, Bishop AJ, Farooqi A, Jazaeri A, Jhingran A, Lin LL, Klopp AH, Amaria R, McQuade J, Glitza I, Guadagnolo A. Gynecologic Melanoma: A 25-Year Institutional Experience. Int J Radiat Oncol Biol Phys 114(3):e266-e267, 2022. PMID: None.
- Guadagnolo BA, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang Y, Wang WL, Ratan R, Somaiah N, Torres KE, Hunt KK, Scally C, Keung E, Satcher RL, Bird J, Lin P, Moon B, Lewis VO, Roland CL, Bishop AJ. Prospective Single-arm Trial of Preoperative 42.75 Gy in 15 Fractions for Soft Tissue Sarcoma of the Extremity/Trunk. Radiation Oncology, Biology, Physics 114(3):S81, 2022. PMID: None.
- Cavazos A, Florez M, De B, Farooqi A, Beckham T, Wang CY, Yeboa D, Bishop A, Briere T, Amini B, Li J, Tatsui C, Rhines L, Ghia A. Long-term Follow up of Patients Receiving Dose-Escalated Treatment of Spinal Metastases Using a Simultaneous Integrated Boost Technique. American Journal of Clinical Oncology- Cancer Clinical Trials 45(9):S11, 2022. PMID: None.
- Guadagnolo B, Mitra D, Farooqi A, Hempel C, Dorber C, Mathai R. Prospective Single-arm Trial of Preoperative 42.75 Gy in 15 Fractions for Soft Tissue Sarcoma. Radiotherapy and Oncology 170(S120):Supplement _1, 2022. PMID: None.
- Cope B, Witt RG, Chiang Y, Seervai R, Fisher S, Lucci A, Wargo J, Jeffrey E, Farooqi A, Bishop AJ, Gershenwald JE, Goepfert R, Wong MK, Guadagnolo BA, Ross MI, Aung PP, Mitra D, Keung EZ. A Single-center Experience of 98 Patients (pts) with Regionally Metastatic Merkel Cell Carcinoma (MCC) of Known (MCCKP) and Unknown (MCCUP) Primary at Presentation. American Society of Clinical Oncology None(None):None, 2022. PMID: None.
- Dharmaiah S, Tadimeti V, Malgulwar PB, Alvarez C, Farooqi A, Huse J. G-Quadruplex Stabilization Enhances Replication Stress and DNA Damage in ATRX-deficient High-Grade Glioma. Neuro- Oncology 23(Supplement_6):vi27-vi28, 2021. PMID: None.
- Bishop AJ, Zheng J, Subramaniam A, Ghia AJ, Wang C, Patel S, Guadagnolo BA, Mitra D, Farooqi A, Kim BYS, Guha-Thakurta N, Li J, Ravi V. High Terminal Hemorrhage Risk From Cardiac Angiosarcoma Brain Metastases Warrants Frequent Brain Imaging and Early Intervention. Int J Radiat Oncol Biol Phys 111(3):e314, 2021. PMID: None.
- Mitra D, Rao PK, Nagarajan P, Bishop AJ, Farooqi A, Gershenwald JE, Wargo J, Keung E, Fisher S, Davies M, Amaria R, Ross MI, Guadagnolo BA. 30-Year Experience Managing Anorectal Melanoma With Sphincter-Sparing Local Excision and Hypofractionated Radiation Therapy. Int J Radiat Oncol Biol Phys 111(3):e60, 2021. PMID: None.
- Farooqi A, Mitchell K, Ludmir EB, Boyce-Fappiano D, Vaporciyan A, Swisher S, Zhang J, Le X, Antonoff M, Gomez D. EGFR Mutations Predict Superior Survival of NSCLC Patients with Oligometastatic Disease Treated with Local Consolidative Therapy. Journal of Thoracic Oncology 16(3):S198, 2021. PMID: None.
- Dharmaiah S, Farooqi A, Alvarez C, Sharin V, Irvin D, Huse J. G-Quadruplex Stabilization Targets ATRX Deficient High-Grade Glioma Via Induction of P53-Independent Apoptosis. Neuro-Oncology 22(2):ii19, 2020. PMID: None.
- Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin P, Diao K, Mitra D, Farooqi A, Lazar A, Roland CL, Bishop AJ. Rethinking the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Int J Radiat Oncol Biol Phys 108(3):e4-e5, 2020. PMID: None.
- Irvin D, Roberts H, Sharin V, Farooqi A, Dharmaiah S, Alvarez C, Huse J. ATRX Deficiency in Glioma Impacts Transcriptional Profiles and the Immune Microenvironment In Vivo. Neuro-Oncology 22(2):ii29, 2020. PMID: None.
- Soliman M, Wang Y, Farooqi A, Bishop AJ, Yeboa DN, McGovern SL, McAleer MF, Briere TM, Campbell M, Tu S, Ferguson S, Rao G, Nieto Y, Li J. Primary Management of Non-Seminomatous Germ Cell Brain Metastases with Stereotactic Radiosurgery: A Case Series. Int J Radiat Oncol Biol Phys 108(3S):e684, 2020. PMID: None.
- Farooqi A, Dharmiah S, Alvarez C, et al. ATRX Mutant Glioblastoma Stem Cell (GSC) Lines with the Alternative Lengthening of Telomeres Phenotype Display Sensitivity to G-Quadruplex Stabilization. Int J Radiat Oncol Biol Phys 105(1):98, 2019. PMID: None.
- Soliman M, Wang Y, Farooqi A, et al. Stereotactic Radiosurgery as Primary Management of Intracranial Germ Cell Metastases. Int J Radiat Oncol Biol Phys 105(1):E90-E91, 2019. PMID: None.
- Ludmir EB, Farooqi A, Mitchell KG, Antonoff M, Gomez DR. Neutrophil-to-Lymphocyte Ratio is an Independent Prognostic Indicator for Overall Survival among Patients with Oligometastatic Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 105(1):E517, 2019. PMID: None.
- Mitchell K, Farooqi A, Ludmir EB, Corsini EM, Vaporciyan A, Swisher SG, Heymach J, Zhang J, Gomez DR, Antonoff M. Improved Overall Survival with Local Consolidative Therapy in Oligometastatic Non-Small Cell Lung Cancer: Results from a Cohort of 194 patients with Synchronous Disease. Int J Radiat Oncol Biol Phys 104(1):229, 2019. PMID: None.
- Moreno A, Choi S, Colbert L, Farooqi A, Umberson K, Korah B, Herman J. Standardizing and optimizing institutional-level documentation in the electronic medical record era. J Clin Oncol 36:155, 2018. PMID: None.
- Farooqi A, Narang S, Li J, Bishop A, McAleer M, Tatsui C, Rhines L, Amini B, Ghia AJ. Early Outcomes of a Novel Hypofractionated Dose Escalated Spine Simultaneous Integrated Boost Technique for Treatment of Metastatic Lesions Not Amenable to Spine Stereotactic Radiosurgery. Int J Radiat Oncol Biol Phys 99(2):E72, 2017. PMID: None.
- Farooqi A, Blanchard P, Bruno T, Kudchadker R, Tang C, Wang J, Venkatesan A, Bathala T, Ma J, Frank SJ. Early Quality of Life Outcomes and Patient Satisfaction Metrics for MRI-Assisted Prostate Brachytherapy Patients. Int J Radiat Oncol Biol Phys 99(2):E230, 2017. PMID: None.
- Farooqi A, Blanchard P, Bruno T, Kudchadker R, Wang J, Venkatesan A, Bathala T, Ma J, Frank SJ. Early Quality of Life Outcomes for MRI-Assisted Prostate Brachytherapy Patients. Brachytherapy 16(3):S108, 2017. PMID: None.
- Komaki R, Wei X, Allen P, Holliday EB, Farooqi A, Lin SH, Balter P, Mohan R, Liao Z, Cox JD. Factors Associated With Severe Pneumonitis for Limited Stage Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 93(3):E436-E437, 2015. PMID: None.
- Farooqi A, Holliday EB, Allen PK, Wei X, Komaki R. Factors influencing brain recurrence and survival among patients with limited-stage small cell lung cancer after complete response to treatment. Int J Radiat Oncol Biol Phys 93(3):S161, 2015. PMID: None.
- Komaki RU, Wei X, Allen PK, Holliday EB, Farooqi A, Lin SH, Welsh JW, Cox JD. Does Prophylactic Cranial Irradiation Improve Overall Survival of Elderly Patients with Limited-Stage Small Cell Lung Cancer?. J Thorac Oncol 10(9):S627-S627, 2015. PMID: None.
- Hazariwala R, Farooqi A, Khan M, Esiashvili N. Cardiopulmonary Outcomes for Concurrent Versus Sequential Lung and Abdominal Irradiation in Stage IV Wilms Tumor. Int J Radiat Oncol Biol Phys 90(1):S728, 2014. PMID: None.
- Woodburn T, Hall H, White K, Calderon R, Blaydes R, Farooqi A, Hogarty M, Mosse Y, Maris J, Erdreich-Epstein A, Miller B, Reynolds CP. Establishing validated pediatric cancer cell lines and direct xenografts from post-mortem samples. Cancer Research 73(8):2786, 2013. PMID: None.
- Farooqi A, Hindle A, Koneru B, Shay J, Reynolds CP. Increased DNA Repair Capacities and p53/MDM2 Pathway Aberrations Hallmark Neuroblastoma Cell Lines with the Alternative Lengthening of Telomeres (ALT) Phenotype. Cancer Research 73(8):580, 2013. PMID: None.
Book Chapters
- Farooqi A, Tang C, Das P. Colorectal Cancer. In: Pocket Radiation Oncology. 1st. Wolters Kluwer, 2019.
- Farooqi A, Yeboa D, Sulman EP. Low-Grade Gliomas. In: Pocket Radiation Oncology. 1st. Wolters Kluwer, 2019.
- Farooqi A, Ludmir EB, Paulino A. Neuroblastoma. In: Pocket Radiation Oncology. 1st. Wolters Kluwer, 2019.
- Farooqi A, Yeboa D, Sulman EP. High-Grade Gliomas. In: Pocket Radiation Oncology. 1st. Wolters Kluwer, 2019.
- Grossberg A, Farooqi A, Taniguchi C. Radiation Biology. In: Pocket Radiation Oncology. 1st. Wolters Kluwer, 2019.
Books (edited and written)
- Tang C, Farooqi A. Pocket Radiation Oncology. Ed(s) 2nd Edition. Wolters Kluwer, 2024.
- Tang C, Farooqi A. Pocket Radiation Oncology. Ed(s) 1st Edition. Wolters Kluwer, 2019.
Letters to the Editor
- Farooqi AS, Bishop AJ. Wrinkles Will Go Where the Smiles Have Been: Dose Escalation in Adult Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 121: 10, 2025.
Grant & Contract Support
| Title: | In vivo assessment of BET blockade combined with PARP inhibition to sensitize MPNST to radiation therapy |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Title: | Targeting the Un- targetable: Restoration of p53 using mRNA- therapeutic for Soft Tissue Sarcoma |
| Funding Source: | Willie Tichenor Fellowship in Sarcoma Research |
| Role: | Co-PI |
| Title: | Leading Clinical Research Faculty Learning Series |
| Funding Source: | MD Anderson Cancer Center |
| Role: | PI |
| Title: | Enhancing Local and Global Access to Accelerated MDACC Radiation Biology Course |
| Funding Source: | Radiation Oncology Strategic Initiatives (ROSI) Education Grant |
| Role: | Co-PI |
| Title: | Targeting the Alternative Lengthening of Telomeres Phenotype in Glioblastoma to Enhance Cellular Response to Radiotherapy |
| Funding Source: | Radiological Society of North America (RSNA) |
| Role: | PI |
Patient Reviews
CV information above last modified December 20, 2024